Sword Health Clinical Validation

October 1, 2022
Sword Health grows 833% over 2021

Since inception, Sword Health has been committed to providing the most clinical-grade digital musculoskeletal (MSK) care in the world.

That’s why we believe clinical validation to be one of the most important ways to differentiate our solution in the marketplace. Sword’s clinical results give companies the most confidence that we are delivering the best possible MSK care for their employee populations.

A number of peer-reviewed studies published in separate medical journals validate our position as the most clinically effective digital solution for acute MSK disorders currently available anywhere. In fact, we are the only digital MSK care company whose acute MSK programs have been validated in peer-reviewed papers.

Read this quick overview of some of our most recent, ground-breaking research.

SHARE THIS ARTICLE
Get the latest news from Sword
Email is required

A life free of pain starts here.

Portugal 2020Norte 2020European UnionPlano de Recuperação e ResiliênciaRepública PortuguesaNext Generation EU